An old post and not my work…1 Dec 2021 20:39
The following highlights many of the reasons why am a buyer at this level:
Dmtr
Share price 1.175 p, market cap 11million (as of today 1/10/21)
52 week high 3.05p, low 1.15p (as of today 1/10/21)
Last results : Sept 2020
Revenues: maiden revenues £1mln
Cash raised £2.1mln July 2020 enough till 2023+
= £4mln in cash as of August 2020
Company aim :
Create a shared data cloud where the platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made and solving an annual $30bln reproducibility crisis in drug and compound development.
Clients include:
Glaxo, Astrazenica , Waters,BASF, Cancer Research Uk, and in July 2020 Novartis and as of Oct 2020 they also gained 5 of the worlds largest pharmacy and agritech
Merck Jan 2021
Major shareholders (top 5) Sept 2020
1 IP group 29.5% and add 50mln of the 140mln new shares
2 Richard Griffiths 7%
3 Springer Nature 7%
4Prof Lee Cronin (scientific founder) 6.5% and added 1.2mln
5 Robert Quested 4.9%
Recent developments 2020
*Feb 2020 Chemify ( linked to Cronin lab) part of a grant funded project in:
"Developing a chemical ontology is the first step towards the digitization of chemistry, the UK pharmaceutical market is set to grow from $32B in 2016 to $43B by 2020, with around 5,000 UK companies in the area. In this proposal, we will interact with key companies (Deep Matter and GSK) "
*Astra/Glaxo form part of the Uk government hub with bases in Oxford, Glasgow and others cities.
* Astrazenica had signed an agreement in 2019 work with DMTR to " transform drug design using innovative digital technologies in combination with automation and AI. To get potential new medicines to patients faster"
*Cancer Research at Beatson Glasgow to divert energy to tracking C19 and signed a deal with DMTR on 14th April for:
the sharing of details of their experiments from anywhere and in real-time
A subsequent deployment in China is anticipated to take place later in 2020.
*June : signs collaboration with one of worlds leading companies in the chemicals sector called Waters.
*July working with £200bln valued Novartis
*Sept confirm record revenues and new customers
*Oct :announce they are working with 5 of largest pharmacy and agritech companies
*Dec 2020 multi year agreement with a world leading company Theines
part of the Thieme Group, an award-winning international medical and science publisher serving health professionals and students for more than 130 years, for the supply of technical data services and access to the Group's proprietary algorithms.
Jan 2021
*Signs deal with Merck
Sign In
Follow the stocks
